Veeva Systems/$VEEV

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Veeva Systems

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Ticker

$VEEV
Sector

Primary listing

NYSE

Employees

7,291

Veeva Systems Metrics

BasicAdvanced
$48B
60.67
$4.86
0.95
-

What the Analysts think about Veeva Systems

Analyst ratings (Buy, Hold, Sell) for Veeva Systems stock.

Bulls say / Bears say

Total revenues for Q2 FY2026 increased 17% year over year to $789.1 million, with subscription services also up 17%, showing continued strong demand for Veeva’s cloud solutions (PRNewswire)
In Q1 FY2026, Veeva reached a $3 billion annual revenue run rate and posted 19% growth in subscription services, hitting an important milestone towards its 2030 goals and highlighting its strong execution (PRNewswire)
Gilead Sciences’ decision to implement Veeva Vault CRM represents a major win with a top-20 pharma company, validating Veeva’s leadership in life sciences commercial software (PRNewswire)
Veeva’s Q2 GAAP EPS came in at $1.19, missing analysts’ expectation of $1.30, indicating that actual earnings growth is lagging behind the pace of subscription revenue growth, which could impact operating leverage (Investor’s Business Daily)
Shares fell 3.6% in after-hours trading despite Veeva beating revenue and EPS forecasts, suggesting investors are unhappy about the lack of a share buyback or other returns of capital to shareholders (Investing.com)
The rollout of Veeva’s initial AI agents is slated for December 2025, which delays any significant revenue from AI and allows competitors additional time to strengthen their generative AI solutions (PRNewswire)
Data summarised monthly by Lightyear AI. Last updated on 7 Nov 2025.

Veeva Systems Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Veeva Systems Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $VEEV

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs